South Sudan
The WHO Representative to South Sudan is Dr Humphrey Karamagi
Juba, South Sudan
Telephone: +211 920 547 017
Email: afwcosswho [at] who.int (afwcosswho[at]who[dot]int)
South Sudan
Latest News
See all
- Life expectancy at birth (years) — m/f (2021)
- 56.5 / 60.6
- Healthy life expectancy at birth (years) (2021)
- 50.5
- Under-five mortality rate (per 1 000 live births) (2023)
- 94.5
- Adult mortality rate 15-60 years (per 1 000 population) — m/f (2021)
- 352.2 / 263.7
- Health expenditure per capita (US$) (2023)
- 72.8
- Health expenditure (% of GDP) (2023)
- 11.6
Source: WHO Global Health Observatory
Donors and partners
- Bill and Melinda Gates Foundation
- Centers for Disease Control and Prevention (CDC)
- Department for International Development (DFID), United Kingdom
- Fondation Sanofi Espoir
- GAVI Alliance
- Global Fund to Fight AIDS, Tuberculosis and Malaria
- Ministry of Foreign Affairs of Denmark
Useful links
Publications
See all
WHO guidelines on leishmaniases: treatment of visceral leishmaniasis and post-kala-azar dermal leishmaniasis in eastern Africa and South-East Asia
WHO's updated guidelines set out treatment recommendations for visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL) in eastern Africa and South-East Asia, the subregion that accounted for 73% of VL cases reported globally to WHO in 2023. They introduce new treatment regimens for PKDL, alternative options for primary VL in eastern Africa, weight-band allometric dosing of miltefosine, and risk-mitigation measures following reports of ocular adverse events.